Free Access
Issue
Med Sci (Paris)
Volume 18, Number 8-9, Août–Septembre 2002
Page(s) 797 - 798
Section Le Magazine : Nouvelles
DOI https://doi.org/10.1051/medsci/20021889797
Published online 15 August 2002
  1. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288 : 669–72. [Google Scholar]
  2. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346 : 1185–93. [Google Scholar]
  3. Baum C, Richters A, Ostertag W. Retroviral vector-mediated gene expression in hematopoietic cells. Curr Opin Mol Ther 1999; 1 : 605–12. [Google Scholar]
  4. Hacein-Bey H, Cavazzana-Calvo M, Le Deist F, et al. Gamma-c gene transfer into SCID X1 patients’ B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. Blood 1996; 87 : 3108–16. [Google Scholar]
  5. Soudais C, Shiho T, Sharara LI, et al. Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer. Blood 2000; 95 : 3071–7. [Google Scholar]
  6. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340 : 508–16. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.